Beranda › Kelainan Genetik
Uji klinis Kelainan Genetik yang merekrut di AS
44 studi untuk Kelainan Genetik merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Washington, DC12 studi
- Philadelphia, PA9 studi
- Houston, TX8 studi
- Durham, NC7 studi
- Mountain View, CA6 studi
- Los Angeles, CA6 studi
- Boston, MA6 studi
- New York City, NY5 studi
- Miami, FL5 studi
- San Diego, CA5 studi
- Dallas, TX4 studi
- Aurora, CO4 studi
- Nashville, TN4 studi
- Chicago, IL4 studi
- Baltimore, MD4 studi
- Columbus, OH4 studi
- Cincinnati, OH4 studi
- Orange, CA3 studi
- Birmingham, AL3 studi
- Atlanta, GA3 studi
- Oakland, CA3 studi
- Ann Arbor, MI3 studi
Berdasarkan negara bagian
- Alabama3 studi
- California17 studi
- Colorado6 studi
- Distrik Columbia3 studi
- Florida7 studi
- Georgia3 studi
- Illinois5 studi
- Maryland14 studi
- Massachusetts6 studi
- Michigan3 studi
- Minnesota5 studi
- Missouri3 studi
- New York7 studi
- North Carolina9 studi
- Ohio7 studi
- Pennsylvania11 studi
- South Carolina3 studi
- Tennessee5 studi
- Texas11 studi
- Wisconsin3 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Genome Medical Sequencing for Gene Discovery
Menerima pesertaStudi observasional
4 Weeks – 99 Years · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT01087320Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia
Menerima pesertaFase 2/3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07441876Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Menerima pesertaStudi observasional
1 Month – 100 Years · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT00246857Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
Menerima pesertaStudi observasionalSukarelawan sehat diterima
2 Months – 115 Years · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT00001373Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT00001405Evaluation of Patients With Immune Function Abnormalities
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT00128973Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Month – 100 Years · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT02450851A Long-Term Observational Study of Patients With Fucosidosis
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07615400Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06016946Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)
Menerima pesertaStudi observasional
7 Months – 15 Months · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT06805695RNA to the RESCUE: Evaluation to Assess the Clinical Utility of RNA Sequencing in Establishing a Genetic Diagnosis or Adjudicating a Previously Established Genetic Diagnosis.
Menerima pesertaStudi observasional
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07787975Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT05587439Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05361811Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders
Menerima pesertaStudi observasionalSukarelawan sehat diterima
30 Days – 99 Years · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT01778504A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT07555483Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07224360Inherited Reproductive Disorders
Menerima pesertaStudi observasional
6 Weeks – 120 Years · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT01500447Prospective Clinical Assessment Study in Children With Hypochondroplasia
Menerima pesertaStudi observasional
30 Months – 16 Years · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT06410976Genetic and Metabolic Disease in Children
Menerima pesertaStudi observasional
1 Day · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT02650622Rett Syndrome Registry
Menerima pesertaStudi observasional
Usia 0 hingga 99 · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT05432349Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
Menerima pesertaFase 2
6 Months – 65 Years · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT03301038ARPKD Database Study
Menerima pesertaStudi observasional
Hingga usia 18 · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT01401998A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT07001280UW Undiagnosed Genetic Diseases Program
Menerima pesertaStudi observasional
Hingga usia 100 · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT04586075Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
Menerima pesertaFase 3
Usia 4 hingga 18 · Pria · Diperbarui 27 Mei 2026 · NCT07608432Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.